Evaluation of Transition With a Heart, a Transition Program for Adolescents With Congenital Heart Disease and Parents

Sponsor
University Hospital, Ghent (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05479630
Collaborator
Universiteit Antwerpen (Other)
81
1
2
84.9
1

Study Details

Study Description

Brief Summary

The department of Congenital Heart Disease of the Ghent University Hospital (Belgium) developed a transition program dedicated to adolescents with congenital heart disease (CHD): 'Transition With a HeartĀ“ (TWAH). TWAH was developed based on the Dutch program 'On your own feetĀ“, starting at the age of 12 years and continuing after transfer. The most vital core components include a general and individualized flowchart, adolescent-centred communication, a joined transfer consultation and an appointed transition coordinator. TWAH focuses on promoting disease knowledge, autonomy and skills development of adolescents with CHD. Interventions encompass the use of a communication-paper, autonomously talking to professionals, individualized education and skills development plan. Interventions were selected from the highest sources of scientific evidence currently available including (quasi-) experimental studies, narrative literature reviews and expert opinions.

TWAH is the intervention in the conducted study. Hence, the intervention group are adolescents with CHD and their parents who are participating in TWAH. Adolescents and their parents who are transferred according to standard care (joined transfer consultation only) are identified as the control group and will be examined in the post test phase in order to be able to make comparisons with the intervention group. At baseline (the start of TWAH) participants of the control group already made the transfer to the adult ward.

The investigators consider the following hypothetical scenario:
  • TWAH will have a positive influence on disease knowledge and transition experiences of the participants.
Condition or Disease Intervention/Treatment Phase
  • Other: Transition With a Heart (TWAH)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
81 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
A prospective quasi-experimental study will be conducted using a pre (intervention group only) - post-test design. In the pre-test only adolescents in the intervention group will be examined as baseline. During the post-test adolescents and parents of both the intervention group and control group will be examined in order to investigate differences between them and to better determine the influence of the intervention on the outcomes.A prospective quasi-experimental study will be conducted using a pre (intervention group only) - post-test design. In the pre-test only adolescents in the intervention group will be examined as baseline. During the post-test adolescents and parents of both the intervention group and control group will be examined in order to investigate differences between them and to better determine the influence of the intervention on the outcomes.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Prospective Quasi-Experimental Study to Evaluate Transition With a Heart, a Transition Project for Adolescents With Congenital Heart Disease and Their Parents With Focus on Disease Knowledge and Transitional Skills
Actual Study Start Date :
Nov 5, 2015
Actual Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adolescents and their parent of the intervention group

Adolescents and their parent who are participating in TWAH

Other: Transition With a Heart (TWAH)
TWAH is a transition program, especially developed for adolescents with CHD and their parents. TWAH is starting at the age of 12 years and continuing after transfer. The most vital core components include a general and individualized flowchart, adolescent-centred communication, a joined transfer consultation and an appointed transition coordinator. TWAH focuses on promoting disease knowledge, autonomy and skills development of adolescents with CHD. Interventions encompass the use of a communication-paper, autonomously talking to professionals, individualized education and skills development plan. Details can be found in De Hosson et al, 2020 (1).

No Intervention: Adolescents and their parent of the control group

Adolescents and their parent who are not participating in TWAH

Outcome Measures

Primary Outcome Measures

  1. Change in disease-related knowledge of adolescents of the intervention group (paired test) [At baseline (first transition outpatient visit around 14y) and through study completion, an average of 1 year from the transfer consultation]

    Total knowledge score assesed by the Leuven Knowledge Questionnaire for Congenital Heart Disease (LKQCHD): and consists of 27 multiple choice questions for girls and 25 items for boys (Philip Moons et al., 2001). The total knowledge score consists of a ratio of the sum of correct answers to the total number of questions resulting in a 0-100 scale, where a higher score reflects a better disease-related knowledge.

  2. Comparison between disease-related knowledge scores of adolescents of the intervention group and adolescents of the control group [Through study completion, an average of 1 year from the transfer consultation]

    Total knowledge score assesed by the Leuven Knowledge Questionnaire for Congenital Heart Disease (LKQCHD): and consists of 27 multiple choice questions for girls and 25 items for boys (Philip Moons et al., 2001). The total knowledge score consists of a ratio of the sum of correct answers to the total number of questions resulting in a 0-100 scale, where a higher score reflects a better disease-related knowledge.

Secondary Outcome Measures

  1. Change in health-related quality of life of adolescents of the intervention group (paired test) [At baseline (first transition outpatient visit around 14y) and through study completion, an average of 1 year from the transfer consultation]

    Level of health-related quality of life of adolescents assesed by the Pediatric Quality of Life inventory (PEDSQoL) adolescent version: cardiac and general module. Adolescents were asked to indicate the degree to which they experienced problems with these respective items over the past month using a five-point Likert scale (from 0=never to 4=always). For calculating the total score, the answers were reversed and computed to the domain and total scores on a 0-100 scale, where a higher score reflects a higher perceived QoL.

  2. Comparison between levels of health-related quality of life of adolescents of the intervention group and adolescents of the control group [Through study completion, an average of 1 year from the transfer consultation]

    Level of health-related quality of life of adolescents assesed by the Pediatric Quality of Life inventory (PEDSQoL) adolescent version: cardiac and general module. Adolescents were asked to indicate the degree to which they experienced problems with these respective items over the past month using a five-point Likert scale (from 0=never to 4=always). For calculating the total score, the answers were reversed and computed to the domain and total scores on a 0-100 scale, where a higher score reflects a higher perceived QoL.

  3. Comparison of transfer experiences between adolescents of the intervention group and the adolescents of the control group [Through study completion, an average of 1 year from the transfer consultation]

    Assesed with the On Your Own Feet Tranfer Experience Scale and consists of two subscales: 1) perceived alignment and collaboration between pediatric and adult care and 2) experienced preparation for transfer, including readiness. The items could be rated on a five-point Likert scale (from 1= strongly disagree to 5=strongly agree). The theoretical scores range from 11 to 55 for the first subscale and 7 to 35 for the second. A higher score reflects a higher level of satisfaction with the transitional process. In addition, the overall satisfaction of the transfer could be indicated using a using visual analogue scale (from 1 if completely unsatisfied to 10 if completely satisfied), as well as confidence in the pediatric cardiologist and the adult cardiologist (from 1= no confidence to 10=complete confidence)

  4. Comparison of transfer experiences between parents in the intervention group and control group [Through study completion, an average of 1 year from the transfer consultation]

    Assesed with the On Your Own Feet Tranfer Experience Scale and consists of two subscales: 1) perceived alignment and collaboration between pediatric and adult care and 2) experienced preparation for transfer, including readiness. The items could be rated on a five-point Likert scale (from 1= strongly disagree to 5=strongly agree). The theoretical scores range from 11 to 55 for the first subscale and 7 to 35 for the second. A higher score reflects a higher level of satisfaction with the transitional process. In addition, the overall satisfaction of the transfer could be indicated using a using visual analogue scale (from 1 if completely unsatisfied to 10 if completely satisfied), as well as confidence in the pediatric cardiologist and the adult cardiologist (from 1= no confidence to 10=complete confidence)

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical diagnosis of a CHD of great or moderate complexity (6)

  • From the age of 12 years or older

  • Must be able to complete the questionnaires

  • Dutch speaking AND/OR

  • Parents having children who are meeting the inclusion criteria above

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ghent University Hospital Ghent Belgium 9000

Sponsors and Collaborators

  • University Hospital, Ghent
  • Universiteit Antwerpen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT05479630
Other Study ID Numbers:
  • 2015-1037
First Posted:
Jul 29, 2022
Last Update Posted:
Jul 29, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Ghent
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 29, 2022